unknown
Stage
About
Contineum Tx is a clinical-stage biopharmaceutical company developing small molecule therapies targeting neuroinflammation, immunology, and fibrotic diseases including idiopathic pulmonary fibrosis, chronic pain, and major depressive disorder.
Explore Contineum Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.